Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |